Pulmonary arterial hypertension (PAH), corresponding to group 1 of pulmonary
hypertension classification, is a rare disease with a major prognostic impact on morbidity …

Systemic sclerosis (SSc) is an autoimmune, multi-organ, connective tissue disease
associated with significant morbidity and mortality. Conventional immunosuppressive …

Introduction Cardiac involvement is common in systemic sclerosis occurring in up to 80% of
patients. Primary myocardial dysfunction results from impairment of coronary microvascular …

Objective To explore the effect of left ventricular (LV) diastolic dysfunction (LVDD) in
systemic sclerosis (SSc)-associated interstitial lung disease (ILD), and to investigate SSc …

Objective Systemic sclerosis sine scleroderma (ssSSc), formally described in 1962, is a
subset of SSc that, unlike limited cutaneous (lcSSc) and diffuse cutaneous (dcSSc) forms …

Cardiac involvement in systemic sclerosis is a common clinical entity that may range from
subclinical to life-threatening complications. The classification of cardiac involvement may …

Objectives Cardiac involvement is common in systemic sclerosis (SSc) patients. In this study,
we aimed to systematically evaluate the relationship between SSc and left ventricular …

Cardiopulmonary complications of connective tissue diseases (CTDs), particularly
pulmonary arterial hypertension (PAH) and interstitial lung disease (ILD), are major …

The clinical course and serological profile of the late-age onset systemic sclerosis (LAO
SSc) and the early-age onset SSc (EAO SSc) was compared. The study enrolled 157 …

Interstitial lung disease (ILD) is a leading cause of both morbidity and mortality in systemic
sclerosis (SSc). Radiographic lung abnormalities on high-resolution computed tomography …